Annual EBITDA:
-$63.98M+$34.35M(+34.93%)Summary
- As of today, MIRM annual EBITDA is -$63.98 million, with the most recent change of +$34.35 million (+34.93%) on December 31, 2024.
- During the last 3 years, MIRM annual EBITDA has risen by +$108.46 million (+62.90%).
- MIRM annual EBITDA is now -2094.00% below its all-time high of -$2.92 million, reached on December 31, 2018.
Performance
MIRM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$8.66M+$7.60M(+712.09%)Summary
- As of today, MIRM quarterly EBITDA is $8.66 million, with the most recent change of +$7.60 million (+712.09%) on September 30, 2025.
- Over the past year, MIRM quarterly EBITDA has increased by +$15.29 million (+230.71%).
- MIRM quarterly EBITDA is now at all-time high.
Performance
MIRM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$17.57M+$15.29M(+46.54%)Summary
- As of today, MIRM TTM EBITDA is -$17.57 million, with the most recent change of +$15.29 million (+46.54%) on September 30, 2025.
- Over the past year, MIRM TTM EBITDA has increased by +$52.92 million (+75.08%).
- MIRM TTM EBITDA is now -26923.08% below its all-time high of -$65.00 thousand, reached on September 30, 2018.
Performance
MIRM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MIRM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +34.9% | +230.7% | +75.1% |
| 3Y3 Years | +62.9% | +127.3% | +87.4% |
| 5Y5 Years | -17.6% | +140.2% | +79.4% |
MIRM EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +62.9% | at high | +126.4% | at high | +87.4% |
| 5Y | 5-Year | -17.6% | +62.9% | at high | +118.3% | at high | +89.8% |
| All-Time | All-Time | -2094.0% | +62.9% | at high | +118.3% | >-9999.0% | +89.8% |
MIRM EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $8.66M(+712.1%) | -$17.57M(+46.5%) |
| Jun 2025 | - | $1.07M(+111.7%) | -$32.86M(+37.2%) |
| Mar 2025 | - | -$9.13M(+49.7%) | -$52.30M(+18.2%) |
| Dec 2024 | -$63.98M(+34.9%) | -$18.17M(-174.0%) | -$63.98M(+9.2%) |
| Sep 2024 | - | -$6.63M(+63.9%) | -$70.49M(+18.4%) |
| Jun 2024 | - | -$18.38M(+11.7%) | -$86.34M(+4.9%) |
| Mar 2024 | - | -$20.80M(+15.7%) | -$90.76M(+5.1%) |
| Dec 2023 | -$98.33M(+22.9%) | -$24.68M(-9.7%) | -$95.62M(+7.9%) |
| Sep 2023 | - | -$22.49M(+1.3%) | -$103.78M(+8.1%) |
| Jun 2023 | - | -$22.79M(+11.2%) | -$112.97M(+6.6%) |
| Mar 2023 | - | -$25.67M(+21.8%) | -$120.91M(+5.2%) |
| Dec 2022 | -$127.54M | -$32.83M(-3.6%) | -$127.54M(+8.8%) |
| Sep 2022 | - | -$31.68M(-3.1%) | -$139.84M(+7.3%) |
| Jun 2022 | - | -$30.74M(+4.8%) | -$150.81M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$32.29M(+28.5%) | -$157.30M(+8.8%) |
| Dec 2021 | -$172.44M(-66.3%) | -$45.14M(-5.8%) | -$172.44M(-5.1%) |
| Sep 2021 | - | -$42.65M(-14.6%) | -$164.09M(-14.7%) |
| Jun 2021 | - | -$37.23M(+21.5%) | -$143.00M(-10.7%) |
| Mar 2021 | - | -$47.43M(-28.9%) | -$129.22M(-24.6%) |
| Dec 2020 | -$103.67M(-90.5%) | -$36.79M(-70.6%) | -$103.67M(-21.4%) |
| Sep 2020 | - | -$21.56M(+8.1%) | -$85.42M(-7.3%) |
| Jun 2020 | - | -$23.45M(-7.2%) | -$79.64M(-13.6%) |
| Mar 2020 | - | -$21.88M(-18.0%) | -$70.14M(-28.9%) |
| Dec 2019 | -$54.42M(-1766.2%) | -$18.54M(-17.5%) | -$54.42M(-51.7%) |
| Sep 2019 | - | -$15.78M(-13.1%) | -$35.88M(-77.9%) |
| Jun 2019 | - | -$13.95M(-126.5%) | -$20.17M(-224.1%) |
| Mar 2019 | - | -$6.16M(-9372.3%) | -$6.22M(-9472.3%) |
| Dec 2018 | -$2.92M | - | - |
| Sep 2018 | - | -$65.00K | -$65.00K |
FAQ
- What is Mirum Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Mirum Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?
- What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Mirum Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of MIRM is -$63.98M
What is the all-time high annual EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high annual EBITDA is -$2.92M
What is Mirum Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, MIRM annual EBITDA has changed by +$34.35M (+34.93%)
What is Mirum Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of MIRM is $8.66M
What is the all-time high quarterly EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high quarterly EBITDA is $8.66M
What is Mirum Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, MIRM quarterly EBITDA has changed by +$15.29M (+230.71%)
What is Mirum Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of MIRM is -$17.57M
What is the all-time high TTM EBITDA for Mirum Pharmaceuticals, Inc.?
Mirum Pharmaceuticals, Inc. all-time high TTM EBITDA is -$65.00K
What is Mirum Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, MIRM TTM EBITDA has changed by +$52.92M (+75.08%)